Clinical Significance of Serum Syndecan-4 in Patients With Drug-induced Interstitial Lung Disease

被引：0
|
作者：
Sato, Y. [1 ]
Tanino, Y. [1 ]
Nikaido, T. [1 ]
Togawa, R. [1 ]
Kawamata, T. [1 ]
Watanabe, N. [1 ]
Wang, X. [1 ]
Fukuhara, N. [1 ]
Kazama, K. [1 ]
Yamada, R. [1 ]
Sato, R. [1 ]
Tomita, H. [1 ]
Suzuki, Y. [1 ]
Saito, J. [1 ]
Kanazawa, K. [1 ]
Shibata, Y. [1 ]
机构：
[1] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3688
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Serum heat shock protein 47 levels in patients with drug-induced lung disease
    Tomoyuki Kakugawa
    Shin-ichi Yokota
    Yuji Ishimatsu
    Tomayoshi Hayashi
    Shota Nakashima
    Shintaro Hara
    Noriho Sakamoto
    Yasuhiro Matsuoka
    Hiroshi Kubota
    Mariko Mine
    Hiroshi Mukae
    Kazuhiro Nagata
    Shigeru Kohno
    Respiratory Research, 14
  • [42] Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
    Tatsuya Nitawaki
    Yoshihiko Sakata
    Kodai Kawamura
    Kazuya Ichikado
    BMC Pulmonary Medicine, 17
  • [43] Drug-induced lung disease
    Özkan, M
    Dweik, RA
    Ahmad, M
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (09) : 782 - +
  • [44] Drug-induced lung disease
    Cooper, JAD
    ADVANCES IN INTERNAL MEDICINE, VOL 42, 1997, 42 : 231 - 268
  • [45] Serum heat shock protein 47 levels in patients with drug-induced lung disease
    Kakugawa, Tomoyuki
    Yokota, Shin-ichi
    Ishimatsu, Yuji
    Hayashi, Tomayoshi
    Nakashima, Shota
    Hara, Shintaro
    Sakamoto, Noriho
    Matsuoka, Yasuhiro
    Kubota, Hiroshi
    Mine, Mariko
    Mukae, Hiroshi
    Nagata, Kazuhiro
    Kohno, Shigeru
    RESPIRATORY RESEARCH, 2013, 14
  • [46] Drug-induced apoptosis: Clinical significance
    Pirmohamed, M
    DRUG METABOLISM REVIEWS, 2003, 35 : 24 - 24
  • [47] Anticancer drug-induced interstitial lung disease: a critical appraisal of clinical practice guidelines and consensus statements
    Zhang, Yi
    Ma, Zhuo
    Sun, Ximu
    Zhang, Yuhui
    Zhu, Min
    Zhang, Shu
    Feng, Xin
    An, Zhuoling
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [48] Insufficient Syndecan-4 is associated with chronic lung disease development in preterm infants
    Matsuzaki, Yohei
    Wang, Xintao
    Tanino, Yoshinori
    Ikeda, Kazushige
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [49] Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease
    Dai, Hua-Ping
    Ma, Fei
    Ren, Yan-Hong
    Chen, Shan-Shan
    Li, Yi-Qun
    CURRENT MEDICAL SCIENCE, 2023, 43 (01) : 1 - 12
  • [50] ANALYSIS OF DRUG-INDUCED INTERSTITIAL LUNG DISEASE CAUSED BY KAMPO MEDICINE IN JAPAN
    Suzuki, T.
    Saito, M.
    Mitsuma, T.
    Niitsuma, K.
    RESPIROLOGY, 2016, 21 : 191 - 191
12345